Measurement of bone turnover in prostate cancer patients receiving intermittent androgen suppression therapy

PURPOSE: Reports on clinical measurements of bone mineral density (BMD) in prostate cancer patients undergoing intermittent androgen suppression therapy (IAS) that allows for hormonal recovery between treatment cycles indicate decreased osteoporosis compared to continuous androgen suppression therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Theyer, Gerhard, Holub, Stefan, Olszewski, Ulrike, Hamilton, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818886/
https://www.ncbi.nlm.nih.gov/pubmed/24198623
http://dx.doi.org/10.2147/OAJU.S13046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818886/
https://www.ncbi.nlm.nih.gov/pubmed/24198623
http://dx.doi.org/10.2147/OAJU.S13046

Ejemplares similares